Translational and Therapeutic Approaches to the Understanding and Treatment of Dyslipidemia.

Zhang, Hanrui; de Aguiar Vallim, Thomas Q; Martel, Catherine

Zhang, Hanrui; de Aguiar Vallim, Thomas Q; Martel, Catherine.

Afiliação

Zhang H; From the Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY (H.Z.); Division of Cardiology, School of Medicine, University of California Los Angeles (T.Q. de A. V.); and Department of Medicine, Montreal Heart Institute Research Center, Université de Montréal, Montreal, Quebec, Canada (C.M.). hz2418@cumc.columbia.edu tvallim@mednet.ucla.edu catherine.martel@icm-mhi.org.
de Aguiar Vallim TQ; From the Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY (H.Z.); Division of Cardiology, School of Medicine, University of California Los Angeles (T.Q. de A. V.); and Department of Medicine, Montreal Heart Institute Research Center, Université de Montréal, Montreal, Quebec, Canada (C.M.). hz2418@cumc.columbia.edu tvallim@mednet.ucla.edu catherine.martel@icm-mhi.org.
Martel C; From the Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY (H.Z.); Division of Cardiology, School of Medicine, University of California Los Angeles (T.Q. de A. V.); and Department of Medicine, Montreal Heart Institute Research Center, Université de Montréal, Montreal, Quebec, Canada (C.M.). hz2418@cumc.columbia.edu tvallim@mednet.ucla.edu catherine.martel@icm-mhi.org.

Arterioscler Thromb Vasc Biol ; 36(7): e56-61, 2016 07.

Article em En | MEDLINE | ID: mdl-27335468

Assuntos

Dislipidemias/tratamento farmacológico; Hipolipemiantes/uso terapêutico; Transporte Biológico; Colesterol/sangue; Proteínas de Transferência de Ésteres de Colesterol/antagonistas & inibidores; HDL-Colesterol/administração & dosagem; HDL-Colesterol/sangue; LDL-Colesterol/sangue; Suplementos Nutricionais; Dislipidemias/sangue; Mutação com Ganho de Função; Humanos; Hipolipemiantes/farmacologia; Receptores X do Fígado/agonistas; Niacina/uso terapêutico; Oligorribonucleotídeos Antissenso/uso terapêutico; Inibidores de PCSK9; Pró-Proteína Convertase 9/sangue; Pró-Proteína Convertase 9/genética; Proteínas Recombinantes/administração & dosagem

Palavras-chave

PCSK9 protein; cardiovascular diseases; cholesterol; cholesterol, HDL; lipids; lipoproteins

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dislipidemias / Hipolipemiantes Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google